What is the NeuroOne Medical Technologies Corporation stock price forecast?

NeuroOne Medical Technologies Corporation is currently trading at $3.25. View real-time AI analysis on Alpha Lenz.

What is NeuroOne Medical Technologies Corporation insider trading activity?

View the latest insider trading data for NeuroOne Medical Technologies Corporation on Alpha Lenz.

What is NeuroOne Medical Technologies Corporation's P/E ratio?

NeuroOne Medical Technologies Corporation's P/E ratio is -6.0.

NeuroOne Medical Technologies Corporation

NASDAQ · NMTC

$3.25-0.07(-2.11%)Pre-market

Ask about NeuroOne Medical Technologies Corporation's future dividend policy...

Alpha Chat Insight

“NeuroOne Medical Technologies Corporation trades at a P/E of -6.0 (undervalued) with modest ROE of -91.3%. 3Y revenue CAGR of 276.0% highlights clear growth momentum.”

Ask for details →

Company Overview

NeuroOne Medical Technologies Corporation is a medical technology company that develops and markets cutting-edge neural surgical solutions. The company's primary focus lies in designing advanced electrode technology for recording and stimulating brain activity, which plays a crucial role in diagnosing and treating various neurological disorders. These electrodes are used for electroencephalography (EEG), electrocorticography (ECoG), and brain stimulation therapies, impacting sectors such as neurology, neurosurgery, and neurodiagnostics. NeuroOne's innovative products aim to address unmet needs in the medical field by providing less invasive and more cost-effective solutions for brain surgeries and therapeutic treatments. Headquartered in the United States, NeuroOne Medical Technologies Corporation is at the forefront of enhancing the capabilities of neural procedures and treatments, potentially transforming how healthcare providers approach neurological conditions.

CEOMr. David A. Rosa M.D.

Websitehttps://nmtc1.com

SectorHealthcare

IndustryMedical Devices

Employees17

Company Statistics

FY 2025

Profile

$21.75MMarket Cap

$9.10MRevenue

0.00Shares Out

17Employees

Margins

56.51%Gross

-41.71%EBITDA

-46.46%Operating

-39.63%Pre-Tax

-39.63%Net

Valuation

-6.03P/E

3.08P/B

2.39EV/Sales

-4.07EV/EBITDA

-7.45P/FCF

Growth (CAGR)

275.98%Rev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-44.63%ROA

-91.34%ROE

-40.50%ROIC

Financial Health

$6.57MCash & Cash Equivalents

$-2.86MNet Debt

52.50%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“NeuroOne Medical Technologies Corporation trades at a P/E of -6.0 (undervalued) with modest ROE of -91.3%. 3Y revenue CAGR of 276.0% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

NeuroOne Medical Technologies Corporation (ticker: NMTC) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 17 employees. Market cap is $22M.

The current price is $3.25 with a P/E ratio of -6.03x and P/B of 3.08x.

ROE is -91.34% and operating margin is -46.46%. Annual revenue is $9M.